Nature Biotechnology
- 24, 1508 - 1511 (2006)
doi:10.1038/nbt1206-1508
Reinventing phage therapy: are the parts greater than the sum?Vincent A Fischetti, Daniel Nelson & Raymond Schuch
Vincent A. Fischetti, Daniel Nelson and Raymond Schuch are at the Laboratory of Bacterial Pathogenesis and Immunology, Rockefeller University, New York, New York 10021, USA. vaf@rockefeller.edu
Although whole phage continue to generate interest as an alternative to antibiotics, focus is shifting to the use of purified phage components as antibacterial agents.
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated.
|
